1-3 of 3
Amanda Enstrom
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study

Catherine Broome, David J Kuter, Keith R. McCrae, Rupert Davies, Amanda Enstrom, Allison Chunyk, Heather Thomas, Allison Naumovski, Steven R. Lentz
Journal: Blood
Blood (2023) 142 (Supplement 1): 5520.
https://doi.org/10.1182/blood-2023-179305
Published: 2023
Journal Articles

Povetacicept (ALPN-303), a Potent Dual BAFF/APRIL Antagonist in Development for the Treatment of Autoimmune Cytopenias, Suppresses Disease in a Mouse Model of Autoimmune Hemolytic Anemia

Katherine E. Lewis, Luana Griffin, Zahra Maria, Amanda Enstrom, Armand R. Bankhead, III, Stanford L. Peng, Stacey R. Dillon
Journal: Blood
Blood (2023) 142 (Supplement 1): 6462.
https://doi.org/10.1182/blood-2023-177786
Published: 2023
Journal Articles

A Randomized, Placebo-Controlled, Phase 1 Study in Healthy Adult Volunteers of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN303, a Potent Dual BAFF/APRIL Antagonist for the Treatment of Autoimmune Cytopenias

Stacey R. Dillon, Rupert Davies, Jason D. Lickliter, Kristi L. Manjarrez, Alina Smith, Mary C. Lessig, Lori Blanchfield, Russell J. Sanderson, Allison Chunyk, Tiffany Blair, Amanda Enstrom, Hany Zayed, Stanford L. Peng
Journal: Blood
Blood (2022) 140 (Supplement 1): 8401–8403.
https://doi.org/10.1182/blood-2022-155908
Published: 2022